Tiziana Life Sciences is trading at $0.96 (-6.59%) on stock-specific volatility, as no direct company news or catalysts have been identified for the move.
- The downward move occurs despite broader U.S. markets trading higher, ruling out index-wide weakness as a primary driver for the decline.
- There are no recent press releases, regulatory filings, or clinical updates from the company to explain the current session's price action.